Epigenetic Modulation of Vasopressin Expression in Health and Disease

• Published in: International journal of molecular sciences Vol. 22; no. 17; p. 9415
• Main Authors: Török, Bibiána, Fazekas, Csilla Lea, Szabó, Adrienn, Zelena, Dóra
• Format: Journal Article
• Language: English
• Published: Basel MDPI AG 01.09.2021; MDPI
• Subjects: Adrenal glands; Adults; Anxiety; Argipressin receptors; Behavior; Blood pressure; DNA methylation; Epigenetics; Fetuses; Gene expression; histone acetylation; Histones; Homeostasis; Hypothalamus; Mental depression; Mental disorders; miRNAs; Nervous system; Neuropeptides; Physiological effects; Review; Schizophrenia; Social behavior; Social discrimination learning; Social factors; Social interactions; Stress; Vasopressin
• ISSN: 1422-0067; 1661-6596; 1422-0067
• DOI: 10.3390/ijms22179415

Vasopressin is a ubiquitous molecule playing an important role in a wide range of physiological processes thereby implicated in the pathomechanism of many disorders. Its effect is well characterized through V2 receptors, which regulates the water resorption in kidney, while its vasoconstrictory effect through V1a receptor also received a lot of attention in the maintenance of blood pressure during shock. However, the most striking is its central effect both through the V1b receptors in stress-axis regulation as well as through V1a receptors regulating many aspects of our behavior (e.g., social behavior, learning and memory). Vasopressin has been implicated in the development of depression, due to its connection with chronic stress, as well as schizophrenia because of its involvement in social interactions and memory processes. Epigenetic changes may also play a role in the development of these disorders. The possible mechanism includes DNA methylation, histone modification and/or micro RNAs, and these possible regulations will be in the focus of our present review.